HONG KONG/BEIJING, Jan 6 (Reuters) – China is in talks with Pfizer Inc. (PFE.N) to obtain a license that will allow domestic drugmakers to manufacture and distribute a generic version …
HEA
-
-
Healthcare
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug
by Ozva Adminby Ozva AdminWASHINGTON, Dec 29 (Reuters) – The US Food and Drug Administration failed to follow its own internal guidelines and practices during Biogen’s approval process. (BIIB.O) Aduhelm, the Alzheimer’s drug, was …
-
Healthcare
China races to install hospital beds as COVID surge sparks concern abroad
by Ozva Adminby Ozva AdminAuthorities rush to add hospital beds and build fever clinics US raises concerns about potential for COVID mutations Beijing reports five more deaths on Tuesday Tight security at crematoria amid …
-
LONDON, Dec 19 (Reuters) – Nicola Osypka’s German company has been selling medical devices used in newborn surgeries in Europe for decades, but new European Union rules have forced it …
-
Healthcare
Exclusive: EU to propose delay to medical device law amid supply worries
by Ozva Adminby Ozva AdminLONDON, Dec 8 (Reuters) – The EU health commissioner will propose on Friday to extend the deadline for companies to comply with a new law regulating medical devices, she told …
-
Thousands of Zantac Lawsuits Dismissed Tuesday The decision bodes well for pending lawsuits: analysts GSK and Sanofi rally adds more than $20 billion to combined mkt cap LONDON, Dec 7 …
-
Healthcare
Rare success for Alzheimer’s research unlocks hope for future therapies
by Ozva Adminby Ozva AdminCHICAGO, Nov 29 (Reuters) – The first breakthrough in 30 years of Alzheimer’s research is giving impetus to clinical trials of “cocktail” treatments that target the two distinctive proteins associated …